Subscribe to RSS
DOI: 10.1055/s-2008-1078761
Fetal Heart Rate Monitoring Patterns in Women with Amniotic Fluid Proteomic Profiles Indicative of Inflammation
Publication History
Publication Date:
29 May 2008 (online)
ABSTRACT
We hypothesized that abnormal fetal heart rate monitoring patterns (FHR-MPs) occur more often in pregnancies complicated by intra-amniotic inflammation. Therefore, our objective was to examine the relationships among FHR-MP abnormalities, intra-amniotic inflammation and/or infection, acute histological chorioamnionitis, and early-onset neonatal sepsis (EONS) in pregnancies complicated by preterm birth. Additionally, the ability of various FHR-MPs to predict EONS was investigated. FHR-MPs from 87 singleton premature neonates delivered within 48 hours from amniocentesis (gestational age, mean ± SD: 28.9 ± 3.3 weeks) were analyzed blindly using strict National Institute of Child Health and Human Development criteria. Strips were evaluated at three time points: at admission, at amniocentesis, and prior to delivery. Intra-amniotic inflammation was established based on a previously validated proteomic fingerprint (mass-restricted score). Diagnoses of histological chorioamnionitis and EONS were based on well-recognized pathological, clinical, and laboratory criteria. We determined that fetuses of women with severe intra-amniotic inflammation had a higher FHR baseline throughout the entire monitoring period and an increased frequency of a nonreactive FHR-MP at admission. Of all FHR-MPs, a nonreassuring test at admission had 32% sensitivity, 95% specificity, 73% positive predictive value, 77% negative predictive value, and 76% accuracy in predicting EONS. Although a nonreassuring FHR-MP at admission was significantly associated with EONS after correcting for gestational age (odds ratio, 5.6; 95% confidence interval, 1.2 to 26.2; p = 0.030), the majority of the neonates that developed EONS had an overall reassuring FHR-MP. Nonreassuring FHR-MPs at either amniocentesis or delivery had no association with EONS. We conclude that in cases complicated by preterm birth, a nonreassuring FHR-MP at the initial evaluation is a specific but not a sensitive predictor of EONS. An abnormal FHR-MP can thus raise the level of awareness that a fetus with EONS may be born, but it is not a useful clinical indicator of the need for antibiotic treatment of the neonate.
KEYWORDS
Preterm labor - fetal heart rate monitoring - chorioamnionitis - prematurity - inflammation - proteomics - neonatal sepsis
REFERENCES
- 1 Renou P, Newman W, Wood C. Autonomic control of FHR. Am J Obstet Gynecol. 1969; 105 949-053
- 2 Van Leeuwen P, Cysarz D, Lange S, Gronemeyer D. Increase in regularity of FHR variability with age. Biomed Tech (Berl). 2006; 51 244-247
- 3 Salafia C M, Ghidini A, Sherer D M, Pezzullo J C. Abnormalities of the FHR in preterm deliveries are associated with acute intra-amniotic infection. J Soc Gynecol Investig. 1998; 5 188-191
- 4 Fleming A D, Salafia C M, Vintzileos A M, Rodis J F, Campbell W A, Bantham K F. The relationships among umbilical artery velocimetry, fetal biophysical profile, and placental inflammation in preterm premature rupture of the membranes. Am J Obstet Gynecol. 1991; 164 38-41
- 5 Salafia C M, Mangam H E, Weigl C A, Foye G J, Silberman L. Abnormal FHR patterns and placental inflammation. Am J Obstet Gynecol. 1989; 160 140-147
- 6 Buhimschi C S, Bhandari V, Hamar B D et al.. Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med. 2007; 4 e18
- 7 Buhimschi C S, Buhimschi I A, Abdel-Razeq S et al.. Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res. 2007; 61 318-324
- 8 Buhimschi I A, Zambrano E, Pettker C M et al.. Using proteomic analysis of the human amniotic fluid to identify histological chorioamnionitis. Obstet Gynecol. 2008; 111 403-412
- 9 Vintzileos A M, Campbell W A, Nochimson D J, Weinbaum P J. The use of the nonstress test in patients with premature rupture of the membranes. Am J Obstet Gynecol. 1986; 155 149-153
- 10 Schiano M A, Hauth J C, Gilstrap III L C. Second-stage fetal tachycardia and neonatal infection. Am J Obstet Gynecol. 1984; 148 779-781
- 11 Day D, Ugol J H, French J I, Haverkamp A, Wall R E, McGregor J A. Fetal monitoring in perinatal sepsis. Am J Perinatol. 1992; 9 28-33
- 12 Salafia C M, Weigl C, Silberman L. The prevalence and distribution of acute placental inflammation in uncomplicated term pregnancies. Obstet Gynecol. 1989; 73 383-389
- 13 Lewis D F, Bergstedt S, Edwards M S et al.. Successful magnesium sulfate tocolysis: is “weaning” the drug necessary?. Am J Obstet Gynecol. 1997; 177 742-745
- 14 Romero R, Yoon B H, Mazor M et al.. A comparative study of the diagnosis performance of amniotic fluid glucose, white blood cell count, interleukin-6, and Gram stain in the detection of microbial invasion in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol. 1993; 169 839-851
- 15 Naef III R W, Allbert J R, Ross E L, Weber B M, Martin R W, Morrison J C. Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol. 1998; 178 126-130
- 16 ACOG Committee Opinion . number 279, December 2002. Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol. 2002; 100 1405-1412
- 17 ACOB Committee on Practice Bulletins-Obstetrics, ACOG Practice Bulletin . number 80, April 2007. Premature rupture of membranes. Obstet Gynecol. 2007; 109 1007-1019
- 18 Electronic FHR monitoring: research guidelines for interpretation. National Institute of Child Health and Human Development Research Planning Workshop. Am J Obstet Gynecol. 1997; 177 1385-1390
- 19 Sameshima H, Ikenoue T, Ikeda T, Kamitomo M, Ibara S. Association of nonreassuring FHR patterns and subsequent cerebral palsy in pregnancies with intrauterine bacterial infection. Am J Perinatol. 2005; 22 181-187
- 20 Edwards R K, Clark P, Locksmith Gregory J, Duff P. Performance characteristics of putative tests for subclinical chorioamnionitis. Infect Dis Obstet Gynecol. 2001; 9 209-214
- 21 Garry D, Figueroa R, Aguero-Rosenfeld M, Martinez E, Visintainer P, Tejani N. A comparison of rapid amniotic fluid markers in the prediction of microbial invasion of the uterine cavity and preterm delivery. Am J Obstet Gynecol. 1996; 175 1336-1341
- 22 Buhimschi I A, Christner R, Buhimschi C S. Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. BJOG. 2005; 112 173-181
- 23 Park J S, Romero R, Yoon B et al.. The relationship between amniotic fluid matrix metalloproteinase-8 and funisitis. Am J Obstet Gynecol. 2001; 185 1156-1161
- 24 Harirah H, Donia S, Hsu C. Amniotic fluid matrix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection. Obstet Gynecol. 2002; 99 80-84
-
25 Naeye R L.
Disorders of the placenta and decidua . In: Naeye RL Disorder of the Placenta, Fetus and Neonate: Diagnosis and Clinical Significance. St. Louis; Mosby 1992: 118-247 - 26 Smulian J C, Bhandari V, Campbell W A, Rodis J F, Vintzileos A M. Value of umbilical artery and vein levels of interleukin-6 and soluble intracellular adhesion molecule-1 as predictors of neonatal hematologic indices and suspected early sepsis. J Matern Fetal Med. 1997; 6 254-259
- 27 Rodwell R L, Leslie A L, Tudehope D I. Early diagnosis of neonatal sepsis using a hematologic scoring system. J Pediatr. 1988; 112 761-767
- 28 Hill J B, Alexander J M, Sharma S K, McIntire D D, Leveno K J. A comparison of the effects of epidural and meperidine analgesia during labor on FHR. Obstet Gynecol. 2003; 102 333-337
- 29 Rotmensch S, Lev S, Kovo M et al.. Effect of betamethasone administration on FHR tracing: a blinded longitudinal study. Fetal Diagn Ther. 2005; 20 371-376
- 30 Ferriero D M. Neonatal brain injury. N Engl J Med. 2004; 351 1985-1995
- 31 Redline R W. Placental pathology and cerebral palsy. Clin Perinatol. 2006; 33 503-516
- 32 ACOG Committee on Obstetric Practice . ACOG Committee Opinion No. 348, November 2006: Umbilical cord blood gas and acid-base analysis. Obstet Gynecol. 2006; 108 1319-1322
- 33 Roberts A B, Goldstein I, Romero R, Hobbins J C. Comparison of total fetal activity measurement with the biophysical profile in predicting intra-amniotic infection in preterm premature rupture of membranes. Ultrasound Obstet Gynecol. 1991; 1 36-39
- 34 Carroll S G, Papaioannou S, Nicolaides K H. Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm prelabor amniorrhexis. Am J Obstet Gynecol. 1995; 172 1427-1435
- 35 Day D, Ugol J H, French J I, Haverkamp A, Wall R E, McGregor J A. Fetal monitoring in perinatal sepsis. Am J Perinatol. 1992; 9 28-33
- 36 Mishra U K, Jacobs S E, Doyle L W, Garland S M. Newer approaches to the diagnosis of early onset neonatal sepsis. Arch Dis Child Fetal Neonatal Ed. 2006; 91 F208-F212
- 37 Rotmensch S, Lev S, Kovo M et al.. Effect of betamethasone administration on fetal heart rate tracing: a blinded longitudinal study. Fetal Diagn Ther. 2005; 20 371-376
Dr. Catalin S Buhimschi
Director of Perinatal Research, Yale University, Department of Obstetrics, Gynecology and Reproductive Sciences
333 Cedar Street, LLCI 804, New Haven, CT 06520